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Objective: Obtaining accurate data about causes of death may be difficult in patients with a 
complicated disease history, including cancer survivors. This study compared causes of death 
derived from medical records (COD
MR
) with causes of death derived from death certificates 
(COD
DC
) as processed by Statistics Netherlands of patients primarily treated for Hodgkin lym-
phoma (HL) or breast cancer (BC).
Methods: Two hospital-based cohorts comprising 1,215 HL patients who died in the period 
1980–2013 and 714 BC patients who died in the period 2000–2013 were linked with cause-of-
death statistics files. The level of agreement was assessed for common underlying causes of death 
using Cohen’s kappa, and original death certificates were reviewed when COD
DC
 and COD
MR
 
showed discrepancies. We examined the influence of using COD
DC
 or COD
MR
 on standardized 
mortality ratio (SMR) estimates.
Results: Agreement for the most common causes of death, including selected malignant 
neoplasms and circulatory and respiratory diseases, was 81% for HL patients and 97% for BC 
patients. HL was more often reported as COD
DC
 (COD
DC
=33.1% vs. COD
MR
=23.2%), whereas 
circulatory disease (COD
DC
=15.6% vs. COD
MR
=20.9%) or other diseases potentially related to HL 
treatment were more often reported as COD
MR
. Compared to SMRs based on COD
DC
, SMRs based 
on COD
MR
 complemented with COD
DC
 were lower for HL and higher for circulatory disease.
Conclusion: Overall, we observed high levels of agreement between COD
MR
 and COD
DC
 for 
common causes of death in HL and BC patients. Observed discrepancies between COD
MR
 and 
COD
DC
 frequently occurred in the presence of late effects of treatment for HL.
Keywords: cause of death, Hodgkin lymphoma, breast cancer, mortality statistics
Introduction
In epidemiology, differences in mortality risks between patient cohorts and the general 
population are usually quantified using standardized mortality ratios (SMRs). SMR esti-
mation requires the availability of age-, sex-, and period-specific mortality rates for the 
general population. Often, these mortality rates are available from nationwide registries. 
It is therefore important that mortality data from official death certificates reflect similar 
underlying cause-of-death patterns as cause-of-death information from medical records. 
Inconsistencies in processing of causes of death may have implications for the interpre-
tation of SMRs in epidemiologic studies. Only few studies compared cause-of-death 
information from medical records or hospital discharge records with death certificates.1–5
In recent years, it has become challenging to obtain cause-of-death information 
in cancer survivor cohorts, especially in case of mortality long after initial cancer 
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treatment. Patients are more often cured and discharged, 
may have changed addresses, and may have died in another 
hospital, hospice or at home. Furthermore, due to the increas-
ing administrative burden on general practitioners (GPs), 
response rates of clinical follow-up questionnaires have 
dropped considerably. To complete information on causes 
of death, linkage with a national cause-of-death registry can 
be considered. However, accurate registration of causes of 
death may be more difficult in patients with a long interval 
between disease diagnosis and date of death or a complicated 
disease history. For example, Hodgkin lymphoma (HL) 
patients are generally young at the time of treatment and 
have an excellent prognosis. Yet, they have an increased risk 
to die from various late adverse events related to treatment, 
including among others, second malignancies, cardiovascu-
lar diseases, and infections.6,7 These late complications may 
affect cause-of-death coding in these patients. In contrast, 
breast cancer (BC) patients also have a good prognosis but 
a lower risk of adverse effects of treatment,8 which may 
lead to less inconsistency in cause-of-death coding. For the 
interpretation of epidemiological studies on cause-specific 
mortality, it is important to gain insight into the effects of 
using cause-of-death information from different sources in 
different populations of cancer survivors.
In this study, we therefore compared causes of death 
recorded in the medical files with cause-of-death information 
from death certificates as processed by the Dutch cause-of-
death statistics (Statistics Netherlands) in patients treated for 
HL or BC. We also examined to what extent differences in 
classification of causes of death influence SMRs.
Methods
We used data from a hospital-based cohort of HL patients 
(n=3,019), treated in the Antoni van Leeuwenhoek hospital, 
Erasmus MC Cancer Institute or Leiden University Medical 
Center, between 1965 and 2000, before the age of 51 years, 
and data from a hospital-based cohort of female BC patients 
(n=5,600) treated in the Antoni van Leeuwenhoek hospital 
for stages I–III invasive BC between 2000 and 2009, before 
the age of 61 years. Patient selection and data collection have 
been described in detail previously.6,9–11,14 For the comparison 
of causes of death, we considered all 1,215 HL patients who 
died in the period 1980–2013 and all 714 BC patients who 
died in the period 2000–2013.
Causes of death for both HL and BC patients were 
obtained from hospital medical records by trained abstrac-
tors. If abstractors had difficulties in assigning a cause of 
death, the patient was discussed within the project team (MS, 
BMPA, FEvL, SdV, JNJ) until agreement was reached. If 
the cause of death could not be retrieved from the hospital 
charts, a questionnaire was sent to the patient’s GP regard-
ing the patient’s medical history and direct and underlying 
causes of death. Response rates from the GPs were 94% in 
200411,12 and 83% in 2012 for the HL cohort13 and 71% in 
2016 for the BC cohort.14 Exact dates of death were confirmed 
through linkage with the Central Office of Genealogy in 
order to allow deterministic linkage of all cohort members 
with Statistics Netherlands. This study was exempt from the 
approval of institutional review board according to Dutch 
law because existing data from medical files were used, 
which was confirmed by the institutional review board of the 
Netherlands Cancer Institute (PTC17.0788). Questionnaires 
obtained from the GPs were anonymized for the researchers, 
as well as the data retrieved from the hospital medical records. 
All analyses were performed at Statistics Netherlands: no 
cause-of-death registry data were exchanged. Original death 
certificates at Statistics Netherlands were reviewed by SdV 
only under a confidentiality agreement.
In the Netherlands, the underlying cause of death for each 
decedent is registered by Statistics Netherlands. Attending 
physicians or medical examiners are obliged to fill out a death 
certificate, which is sent to Statistics Netherlands through 
the municipality where the death occurred. At Statistics 
Netherlands, the death certificates are coded and an underly-
ing cause is selected according to the tenth revision of the 
ICD (ICD-10), with a maximum of four coded diseases per 
decedent. The ICD-10 defines the underlying cause of death 
as 1) the disease or injury that initiated the train of morbid 
events leading directly to death or 2) the circumstances of 
the accident or violence that produced the fatal injury, with 
Volume 2 of ICD-10 providing several instructions for the 
application of this definition.15 Detailed information on 
methods of registration of causes of death in the Netherlands 
has been published previously.16,17
The hospital-based cohorts of HL and BC patients were 
linked with the causes of death at Statistics Netherlands to 
enable comparison of the causes of death derived from the 
medical records (COD
MR
) with causes of death derived from 
the death certificates (COD
DC
). Individual-level linkage was 
based on sex, date of birth, date of death, and filing munici-
pality (first linkage step). If linkage failed due to missing 
information on filing municipality in the cohort data, linkage 
was based on the remaining three variables (second linkage 
step). Additionally, we performed a third linkage procedure 
where we varied parts of the linkage key (eg, day of death or 
day of birth). By chance, it is possible that two individuals 
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have an identical linkage key (0.05% of total on the first link-
age step and 1.3% on the second linkage step in the period 
1980–2013). However, we checked for duplicate matches in 
both cohorts on the first two linkage keys and found none. 
Linkage was successful for 1,140 deceased patients (93.8%) 
in the HL cohort and 690 deceased patients (96.6%) in the 
BC cohort. The difference in successful linkages can be 
understood when realizing that deaths within the HL cohort 
partly occurred in earlier decades.
statistical analyses
We compared the COD
MR
 and the COD
DC
 for common 
causes of death according to the ICD-10, including malig-
nant neoplasms and circulatory disease, for all patients who 
were successfully linked with Statistics Netherlands. The 
causes of death of patients for whom the cause of death in 
our cohort was missing (unable to retrieve from the medi-
cal records and no response from the GP), or unspecified 
(ICD-10 codes R96–R99) were categorized as unknown or 
unavailable, including for 373 deceased HL patients (32.2%) 
and 113 deceased BC patients (16.4%). We calculated the 
conditional agreement between the COD
MR
 and the COD
DC
 in 
patients for whom the cause of death was available from both 
sources, thus excluding patients with unknown or unavailable 
cause of death. Conditional agreement for medical records 
was defined as the number of deceased patients for whom 
COD
MR
 was in agreement with COD
DC
 divided by the total 
number of deaths from a specific cause according to COD
MR
 
and vice versa for the conditional agreement for death certifi-
cates. Overall agreement between COD
MR
 and COD
DC
 was 
calculated by dividing the number of patients for whom the 
causes of death from COD
MR
 and COD
DC
 agreed by the total 
number of deceased patients. To adjust for chance agreement, 
the Cohen’s kappa statistic was calculated. Kappa values of 
>0.75 were considered to represent excellent agreement, 
values of 0.40–0.75 represented moderate agreement, and 
values of <0.40 represented poor agreement.18
The original death certificates were reviewed when 
COD
MR
 differed from COD
DC
. Discrepancies were exam-
ined when HL was coded as COD
MR
 but not as COD
DC
, or 
vice versa, in the HL cohort. Similarly, discrepancies were 
further examined when BC was coded as COD
MR
 and but 
not as COD
DC
, or vice versa, in the BC cohort. Additionally, 
discrepancies between COD
MR
 and COD
DC
 were investigated 
when in the HL cohort, both COD
MR
 and COD
DC
 concerned a 
common malignancy as cause of death (including lung can-
cer, gastrointestinal cancer, non-HL and leukemia) or when 
COD
MR
 was recorded as a common malignancy and COD
DC
 
specified circulatory disease, or vice versa. For examination 
of such discrepancies, only original death certificates filed 
between 1980–1989 and 2000–2013 were accessible.
Finally, we assessed whether and to what extent discrep-
ancies in causes of death influenced the results of person-
year analyses of cause-specific mortality. We compared the 
observed mortality in our HL cohort and mortality in the 
general population, taking into account the person-years of 
observation of patients in our cohort by age, sex, and calen-
dar period. Mortality data for the general population from 
Statistics Netherlands for the period 1980–2013 were used 
as reference rates. In this analysis, time at risk began at start 
of treatment and ended at date of death, date of emigration, 
or December 31, 2013, whichever came first. SMRs were 
calculated as the ratio of the observed and expected number 
of deaths in our HL cohort, and the confidence limits were 
calculated using exact Poisson probabilities of observed 
numbers. The absolute excess risk (AER) was calculated as 
the observed minus the expected number of deaths divided by 
person-years at risk, expressed per 10,000 person-years. First, 
we performed the analysis using COD
MR
 supplemented by 
COD
DC
 if COD
MR
 was missing. Subsequently, we performed 
the analysis using only COD
DC
. Lastly, we performed the 
analysis in the same way as the first analysis, and we addition-
ally supplemented COD
MR
 with COD
DC
 if the data between 
the two sources showed discrepancy.
Results
In total, we included 1,140 deceased HL patients and 690 
deceased BC patients for whom linkage with Statistics 
Netherlands could be performed. Table 1 shows the descrip-
tive characteristics of both patient groups. The majority 
of deceased HL patients were male (61.8%). Median age 
at primary cancer diagnosis was 30.4 years (interquartile 
range [IQR]=23.7–38.6) for HL patients and 50.3 years 
(IQR=42.7–55.6) for BC patients. For HL patients, the 
median interval between HL treatment and death was 17.4 
(IQR=8.0–27.0), and for BC patients, this interval was 
4.3 years (IQR=2.4–6.8). Cause of death was available from 
both the medical records and death certificates for 767 HL 
patients and 577 BC patients.
The level of agreement between medical records and 
death certif icates for common causes of death in HL 
patients (including HL; breast, lung, and gastrointestinal 
cancers; non-HL and leukemia; other malignant neoplasms; 
circulatory disease; and respiratory disease) is shown in 
Table 2. Using either COD
MR
 or COD
DC
, the majority of 
patients died from a malignant neoplasm (66.5% and 75.9%, 
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 respectively). According to COD
MR
, 23.2% of all patients 
died from HL compared to 33.1% according to COD
DC
. 
When the COD
DC
 stated HL, only in 63% of deaths, COD
DC
 
and COD
MR
 agreed. The conditional agreement for HL as 
COD
MR
 was 89.9%, while the corresponding Cohen’s kappa 
value of 0.64 indicated moderate agreement. On the other 
hand, for breast, lung, and gastrointestinal cancers, excel-
lent agreement was observed between COD
MR
 and COD
DC
 
in HL patients (corresponding Cohen’s kappa: 0.91, 0.79, 
and 0.83, respectively). HL patients more often died from 
cardiovascular disease according to COD
MR
 than according to 
COD
DC
 (20.9% vs. 15.6%, respectively). For ischemic heart 
disease, the conditional agreement was 57.8% for COD
MR
 
and 46.4% for COD
DC
, with a corresponding kappa value 
of 0.48. The conditional agreement for other heart diseases 
was low for COD
MR
 (18.1%), and the corresponding kappa 
Table 1 Descriptive characteristics of deceased hl and BC patients
Characteristics HL, n (%) BC, n (%)
Total cohort 1,140 (100) 690 (100)
Females in cohort 435 (38.2) 690 (100)
Calendar period of cancer diagnosis
1965–1979 598 (52.5)
1980–1989 380 (33.3)
1990–2000 162 (14.2)
2000–2009 690 (100)
age at diagnosis of cancer, median (iQr) 30.4 (23.7–38.6) 50.3 (42.7–55.6)
age at death, median (iQr) 50.3 (38.8–59.7) 54.9 (47.4–61.0)
Time interval between cancer diagnosis and death, median (iQr) 17.4 (8.0–27.0) 4.3 (2.4–6.8)
Calendar period of death
1980–1989 288 (25.3)
1990–1999 336 (29.5)
≥2000 516 (45.3) 690 (100)
Abbreviations: hl, hodgkin lymphoma; BC, breast cancer; iQr, interquartile range.
Table 2 Level of agreement between causes of death from medical records and death certificates in HL patients
Cause of death Number of deaths 
according to 
medical records (%)
Number of deaths 
according to death 
certificates (%)
Conditional 
agreement in medical 
recordsa (%)
Conditional 
agreement in death 
certificatesb (%)
Cohen’s 
kappa
Malignant neoplasm 510 (66.5) 582 (75.9) 96.5 84.5 0.66
gastrointestinal cancer 70 (9.1) 76 (9.9) 88.6 81.6 0.83
lung cancer 88 (11.5) 93 (12.1) 84.1 79.6 0.79
BC 26 (3.4) 31 (4.0) 100 83.9 0.91
hl 178 (23.2) 254 (33.1) 89.9 63.0 0.64
Circulatory disease 160 (20.9) 120 (15.6) 63.8 85.0 0.67
ischemic heart disease 45 (5.9) 56 (7.3) 57.8 46.4 0.48
Other heart diseases 83 (10.8) 24 (3.1) 18.1 62.5 0.24
Notes: Cause of death according to the iCD-10: malignant neoplasms (C00–C97), gastrointestinal cancer (C15–C26), lung cancer (C33–C34), BC (C50), hl (C81), 
circulatory disease (i00–i99), ischemic heart disease (i20–i25), and other heart diseases (i30–i51). aConditional agreement in medical records is defined as number of deaths 
in agreement with death certificates divided by the total number of deaths from a specific cause of death. bConditional agreement in death certificates is defined as number 
of deaths in agreement with medical records divided by the total number of deaths from a specific cause of death.
Abbreviations: hl, hodgkin lymphoma; BC, breast cancer.
value of 0.24 reflected poor level of agreement between 
COD
MR
 and COD
DC
. The overall agreement between COD
MR
 
and COD
DC
 for common causes of death in HL patients was 
81.4%, excluding other, unknown, and unavailable causes 
of death (Table 3). Including all other causes of death, the 
overall agreement was 70.8%. Among patients for whom the 
COD
DC
 was HL, 29 out of 365 patients died from non-HL 
or leukemia according to COD
MR
. Similarly, 10 out of 180 
patients who died of HL according to COD
MR
, died from 
non-HL or leukemia according to COD
DC
. Additionally, a 
substantial part of HL patients who died of HL according to 
COD
DC
 died from circulatory disease according to COD
MR
 
(22 out of 164 patients).
In addition in BC patients, malignant neoplasm was the 
most important cause of death (Table 4). When the COD
MR
 
was BC, in 95.4% of deaths, the COD
DC
 was also BC, 
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 resulting in a conditional agreement in COD
DC
 of 95.0%. The 
corresponding Cohen’s kappa value of 0.75 indicated high 
agreement between COD
MR
 and COD
DC
. Kappa values also 
indicated excellent agreement between COD
MR
 and COD
DC
 
for lung cancer (0.78) and gastrointestinal cancer (0.80) in 
BC patients. For BC patients, a higher overall agreement 
between COD
MR
 and COD
DC
 for common causes of death 
was observed compared to HL patients (Table S1). Here, 
the overall agreement for breast, lung, and gastrointestinal 
cancers; other malignant neoplasms; and circulatory disease 
was 96.6%. Including other causes of death, the overall 
agreement was 91.7%.
For 70 out of 109 deceased HL patients for whom COD
MR
 
and COD
DC
 differed, death certificates were filed in the years 
that were available for review (Table 5). When COD
MR
 was 
attributed to HL, seven discrepancies were due to the lack 
of specification by the physician, eg, NHL or “lymphoma” 
was stated on the death certificate rather than HL, and three 
discrepancies reflected coding errors by the registration 
clerk. When COD
DC
 was recorded as HL, 16 discrepancies 
were caused by the fact that the physician filing the death 
certificate related the cause of death to late adverse events 
of treatment for HL, which was, however, diagnosed >10 
years prior to death in patients cured of HL, eg, “lung fibrosis 
after radiotherapy for the treatment of HL” was stated on the 
death certificate.
For 41 out of 42 deceased BC patients for whom we 
observed discrepancies between COD
MR
 and COD
DC
, death 
certificates were available for review (Table S2). Of the 21 
deaths attributed to BC in the COD
MR
 but not in the COD
DC
, 
the discrepancy was once due to a coding error and the 
COD
DC
 was once attributed to an external cause of death 
without BC being mentioned on the death certificate. No 
explanation could be found for the remaining 19 discrep-
ancies. In none of the 20 discrepancies where COD
DC
 was 
attributed to BC while the COD
MR
 was recorded as another 
disease, an explanation could be found.
Table 6 shows the results of the person-year analysis of 
cause-specific mortality for common causes of death in HL 
patients, using COD
MR
 complemented with COD
DC
 when 
COD
MR
 was missing and, alternatively, using COD
DC
 only. 
Compared to SMRs based on COD
DC
 only, SMRs based on 
COD
MR
 complemented with COD
DC
 were higher for circula-
tory disease (SMR=5.9; 95% CI=5.2–6.6 vs. SMR=4.6; 95% 
CI=4.0–5.2, P<0.05). Conversely, SMRs were lower for HL 
(SMR=1,030; 95% CI=917–1,152 vs. SMR=1,249; 95% 
CI=1,124–1,384, P<0.05). These differences are reflected 
in the AERs as well, especially for HL as cause of death. T
ab
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The SMRs in the person-year analysis, where we comple-
mented COD
MR
 with COD
DC
 and where we supplemented 
COD
MR
 with COD
DC
 when these causes of death showed 
discrepancy, approximated the results of the analysis where 
we used COD
DC
 only.
Discussion
Overall, we observed high agreement when comparing causes 
of death from medical records and death certificates. Among 
Table 4 Level of agreement between causes of death from medical records and death certificates in BC patients
Cause of death Number of deaths 
according to medical 
records (%)
Number of deaths 
according to death 
certificates (%)
Conditional 
agreement in medical 
recordsa (%)
Conditional 
agreement in death 
certificatesb (%)
Cohen’s  
kappa
Malignant neoplasm 544 (94.3) 554 (96.0) 99.1 96.6 0.63
gastrointestinal cancer 12 (2.1) 18 (3.1) 100 66.7 0.80
lung cancer 22 (3.8) 29 (5.0) 90.9 69.0 0.78
BC 478 (82.8) 476 (82.5) 95.4 95.0 0.75
Circulatory disease 11 (1.9) 4 (0.7) 36.4 100 0.53
Notes: Cause of death according to the iCD-10: malignant neoplasms (C00–C97), gastrointestinal cancer (C15–C26), lung cancer (C33–C34), BC (C50), and circulatory 
disease (i00–i99). aConditional agreement in medical records is defined as number of deaths in agreement with death certificates divided by the total number of deaths from a 
specific cause of death. bConditional agreement in death certificates is defined as number of deaths in agreement with medical records divided by the total number of deaths 
from a specific cause of death.
Abbreviation: BC, breast cancer.
Table 5 Causes of discrepancies between causes of death from medical records and causes of death from death certificates in HL 
patients
n % Comments
HL as cause of death from medical records, other cause of death based on death certificates
10 66 Coding or filing error
7 47 Filing error on death certificate (physician stated “NHL” or “lymphoma”)
3 20 Coding error by registration clerk
2 13 External cause of death
1 7 Cause of death from medical records mentioned on death certificatea
1 7 Cause of death from death certificates registered in medical recordsb
3 20 No explanationc
2 13 Malignant neoplasm stated as cause of death on death certificate, not registered in medical records
1 7 Malignant neoplasm stated as cause of death on death certificate, registered in medical records
3 20 Cause of death from medical records not stated on death certificate
15 100
HL as cause of death from death certificates, other causes of death based on medical records
16 29 Physician relates cause of death to HL diagnosis >10 years prior to deathd
7 34 Cause of death from medical records stated on death certificate, but not as underlying cause of deathe
4 7 Cause of death from medical records related to diagnosis stated on death certificate
5 9 Cause of death from medical records not stated on death certificate
39 71 No explanation
15 27 Cause of death from medical records stated on death certificate, but not as underlying cause of death
7 13 Cause of death from medical records related to diagnosis stated on death certificatef
17 31 Cause of death from medical records not stated on death certificate
55 100
Notes: aThe death certificate stated that the patient committed suicide because there were no further options for the treatment of HL. bThe death certificate stated that the 
patient had euthanasia for BC. cnumbers do not add up to 100%; multiple comments possible when no explanation was found. dThe physician stated on the death certificate: 
“chemotherapy or radiotherapy for the treatment of HL”. eThe death certificate stated for example “cardiomyopathy after chemotherapy and radiotherapy for the treatment 
of HL”. fThe death certificate stated for example “heart failure”, whereas the medical records stated “cardiomyopathy”.
Abbreviations: hl, hodgkin lymphoma; nhl, non-hodgkin lymphoma; BC, breast cancer.
HL patients, an overall agreement of 81% was observed 
for common causes of death. However, COD
MR
 more often 
stated cardiovascular disease, whereas COD
DC
 was more 
often recorded as HL. Differences between COD
MR
 and 
COD
DC
 were much smaller for BC patients. The majority of 
BC patients died from BC itself, and a high overall agree-
ment (97%) was observed between COD
MR
 and COD
DC
. We 
compared SMRs based on different sources of data in our HL 
cohort and observed a lower SMR for HL and a higher SMR 
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for circulatory disease when using COD
MR
 complemented 
with COD
DC
 compared to using COD
DC
 only. We only calcu-
lated SMRs for the HL cohort, since very few discrepancies 
were observed for common causes of death in the BC cohort, 
and only a small number of missing causes of death from 
the medical records would need to be complemented with 
the causes of death from the death certificate. Therefore, 
we do not expect to find more than minor differences in the 
calculated SMRs in the BC cohort. We assessed discrepan-
cies at an individual level by reviewing original death cer-
tificates when differences were observed between COD
MR
 
and COD
DC
. However, no explanations could be found for 
most of these discrepancies. In our study, linkage errors are 
minimal and we do not expect that these errors explain the 
observed discrepancies. Part of the discrepancies between 
COD
MR
 and COD
DC
 in HL patients could be explained by the 
fact that the physician attributed the cause of death on the 
death certificate to a potential late adverse effect of treatment 
for HL. However, as the patient was cured of HL according 
to the medical record, recording of HL as a cause of death 
does not seem to be correct. In addition, for an individual 
patient, causality of an exposure-disease sequence can never 
be established. Here, we must keep in mind that COD
MR
 
and COD
DC
 are collected for different purposes. In research 
Table 6 Person-year analysis on cause-specific mortality using different cause-of-death data in HL patients
Cause of death Observed causes of death from 
medical records, complemented 
with death certificatesa 
Observed causes of death  
from death certificates onlyb 
 
Observed causes of death from 
medical records, discrepancies 
supplemented with death 
certificatesc
O E SMR  
(95% CI)
AER O E SMR  
(95% CI)
AER O E SMR  
(95% CI)
AER
Malignant neoplasms 743 69.8 10.6 (10.0–11.6) 129.3 804 69.8 11.5 (10.7–12.3) 141.0 828 69.8 11.9 (11.1–12.7) 145.6
gastrointestinal cancer 105 18.4 5.7 (4.7–6.9) 16.6 108 18.4 5.9 (4.8–7.0) 17.2 111 18.4 6.0 (5.0–7.2) 17.8
lung cancer 120 18.4 6.5 (5.4–7.8) 19.5 121 18.4 6.6 (5.5–7.9) 19.7 125 18.4 6.8 (5.7–8.1) 20.5
BC 34 7.4 4.6 (3.2–6.4) 5.1 37 7.4 5.0 (3.5–6.9) 5.7 38 7.4 5.1 (3.6–7.0) 5.9
hl 301 0.3 1,029.7
(916.6–1,152.8)
57.8 365 0.3 1,248.6  
(1,123.8–1,383.5)d
70.1 368 0.3 1,258.9  
(1,133.5–1,394.3)
70.6
nhl 50 2.0 24.6 (18.2–32.4) 9.2 60 2.0 29.5 (22.5–38.0) 11.1 67 2.0 32.9 (25.5–41.8) 12.5
leukemia 29 1.9 15.0 (10.0–21.5) 5.2 23 1.9 11.9 (7.5–17.8) 4.0 24 1.9 12.4 (8.0–18.5) 4.2
infectious and parasitic 
diseases
32 2.6 12.4 (8.4–17.4) 5.6 16 2.6 6.2 (3.5–10.0) 2.6 18 2.6 6.9 (4.1–11.0) 3.0
Circulatory disease 257 43.8 5.9 (5.2–6.6) 41.0 200 43.8 4.6 (4.0–5.2)d 30.0 213 43.8 4.9 (4.2–5.6) 32.5
respiratory disease 37 8.0 4.6 (3.2–6.4) 5.6 31 8.0 3.9 (2.6–5.5) 4.4 32 8.0 4.0 (2.7–5.6) 4.6
Notes: aCause of death was based on information from the medical records and supplemented with information from death certificates when the cause of death was 
unknown or unavailable from the medical records. bCause of death was based on information from the death certificates only. cCause of death was based on information from 
the medical records and supplemented with information from death certificates when the cause of death was unknown or unavailable from the medical records or when the 
cause of death was discrepant between the medical records and death certificates. dstatistical comparison between sMrs from the analysis using observed causes of death 
from medical records complemented with death certificates and using observed causes of death from death certificates only showed a statistically significant difference at 
a P-value of <0.05. here, we assumed that the covariance between the different sMrs was zero. since the two samples were not independent, covariance will be positive, 
resulting in a smaller P-value. Comparisons remain inconclusive when we observe a nonstatistically significant difference between SMRs at a covariance of zero.
Abbreviations: hl, hodgkin lymphoma;  nhl, non-hodgkin lymphoma; O, observed; E, expected; sMr, standardized mortality ratio; aEr, absolute excess risk.
focusing on the prognosis of HL or long-term adverse events 
of HL treatment, it is undesirable to code HL as the underly-
ing cause of death when a patient is cured of HL and dies 
from a potential late effect of HL treatment. For example, 
when a physician states “cardiomyopathy as a consequence 
of chemotherapy for the treatment of HL”, the COD
DC
 will 
be coded as HL, whereas in late effects research, the COD
MR
 
would be attributed to cardiomyopathy.
When interpreting the results of this study, it is important 
to keep in mind that COD
MR
 and COD
DC
 have been assessed 
in different ways. To obtain causes of death from HL and 
BC patients, we reviewed the medical files. If the cause of 
death could not be retrieved, a questionnaire was sent to the 
patient’s GP. Thus, where Statistics Netherlands has to rely on 
the physician who fills in the death certificate, in our research 
setting, we were able to utilize more information from medi-
cal records to obtain COD
MR
. Acknowledging these differ-
ences between COD
MR
 and COD
DC
, the question arises what 
level of agreement can be reached when comparing COD
MR
 
and COD
DC
. Statistics Netherlands previously assessed the 
reliability of coding an underlying cause of death from death 
certificates.16 The reliability of the cause-of-death statistics, 
assessed by coding the same death certificate by different 
registration clerks, ranged from high (>90%) for major causes 
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of death such as cancers and acute myocardial infarction to 
low (<70%) for chronic diseases. In the current study, we 
observed an overall agreement for common causes of death 
of 71% in HL patients and 92% in BC patients. Relating these 
findings to the reliability study of Statistics Netherlands, the 
level of agreement in the current study is comparable with 
known variability in determining cause of death.
Among HL patients, our most important finding was 
that COD
MR
 was more often attributed to cardiovascular 
disease, whereas COD
DC
 was more often attributed to HL. 
This indicates that HL is more often recorded in the cause-
of-death statistics files than we would expect from a clinical 
perspective, leading to an overestimation of mortality from 
HL. Our comparison between COD
MR
 and COD
DC
 showed 
that discrepancies were more frequent within the HL cohort 
than those in the BC cohort. BC patients most often died 
from BC itself within a short period of time, whereas a 
substantial number of HL patients died years after the ini-
tial HL diagnosis. Although there are differences between 
HL and BC patients in the calendar period of cancer diag-
nosis, follow-up time, and age at treatment, discrepancies 
in cause of death appear to be more frequent when deaths 
occurred after a relatively long period of follow-up, when 
the likelihood of deaths due to late adverse events related 
to treatment is higher.
Conclusion
We observed high levels of agreement between COD
MR
 and 
COD
DC
 for common causes of death in HL and BC patients. 
However, differences were observed in the attribution of HL 
and circulatory disease as causes of death between COD
MR
 
and COD
DC
. Observed discrepancies between COD
MR
 and 
COD
DC
 frequently occurred in the presence of late effects of 
treatment for HL; HL was more often recorded as COD
DC
, 
whereas the COD
MR
 more often concerned potential late 
effects of treatment. In future studies, researchers should 
keep in mind that differences in causes of death may arise 
when examining long-term mortality in cancer patients using 
different sources of cause-of-death data.
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Supplementary materials
Table S1 Causes of death according to medical records and death certificates in BC patients
      Death certificates
Medical records
BC Lung  
cancer
Gastrointestinal 
cancer
Other  
malignant 
neoplasms
Circulatory 
disease
Other  
causes of 
death
Unknown  
and  
unavailablea
Total  
medical  
records
BC 456 7 3 8 0 4 5 483
lung cancer 2 20 0 0 0 0 0 22
gastrointestinal cancer 0 0 12 0 0 0 0 12
Other malignant neoplasms 5 1 2 25 0 1 0 32
Circulatory disease 5 0 0 0 4 2 0 11
Other causes of death 8 1 1 0 0 12 0 22
Unknown and unavailablea 69 8 8 4 8 11 0 108
Total number in registry data 545 37 26 35 12 30 5 690
Notes: Cause of death according to the iCD-10: BC (C50), lung cancer (C33–C34), gastrointestinal cancer (C15–C26), and circulatory disease (i00–i99). aUnknown and 
unavailable causes of death include iCD-10 codes r96–r99 and cases where no information on cause of death in medical records or no response from the gP could be 
obtained.
Abbreviations: BC, breast cancer; gP, general practitioner.
Table S2 Causes of discrepancies between causes of death from medical records and causes of death from death certificates in BC 
patients
n % Comments
BC as cause of death from medical records
1 5 Coding error
1 5 Coding error by registration clerk (“ovarian cancer” instead of “BC”)
1 5 External cause of death
1 5 Cause of death from medical records not mentioned on death certificate
19 21 No explanationa
9 47 Malignant neoplasm stated as cause of death on death certificate, not registered in medical records
4 21 Malignant neoplasm stated as cause of death on death certificate, registered in medical records
6 32 Cause of death from medical records stated on death certificate, but not as underlying cause of death
1 5 Cause of death from medical records related to diagnosis stated on death certificate
12 63 Cause of death from medical records not stated on death certificate
21 100
BC as cause of death from death certificates
20 100 No explanation
7 35 Cause of death from medical records stated on death certificate, but not as underlying cause of death
6 30 Cause of death from medical records related to diagnosis stated on death certificate
7 35 Cause of death from medical records not stated on death certificate
20 100
Note: anumbers do not add up to 100%; multiple comments possible when no explanation was found.
Abbreviation: BC, breast cancer.
